Klotho in acute kidney injury: biomarker, therapy, or a bit of both?
- PMID: 21116272
- DOI: 10.1038/ki.2010.367
Klotho in acute kidney injury: biomarker, therapy, or a bit of both?
Abstract
Acute kidney injury (AKI) diagnosis is based on an increase in serum creatinine or a decrease in urine output. To be effective, treatment of AKI should be started very early after the insult and well before the rise of serum creatinine. Thus, sensitive biologic markers of renal tubular injury in AKI are strongly needed. Hu et al. suggest that Klotho could be a novel biomarker and therapeutic target of ischemia-induced AKI.
Comment on
-
Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective.Kidney Int. 2010 Dec;78(12):1240-51. doi: 10.1038/ki.2010.328. Epub 2010 Sep 22. Kidney Int. 2010. PMID: 20861825 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
